In a world covered with sensors and satellites, access to high-quality data that can help solve problems and improve systems ...
Already approved for progressive multiple sclerosis, ocrelizumab in a second phase 3 study demonstrates meaningful clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback